Can Wellbutrin Cause Hyponatremia?
Yes, bupropion (Wellbutrin) can cause hyponatremia, though this adverse effect is uncommon and occurs far less frequently than with SSRIs or SNRIs.
Evidence for Bupropion-Induced Hyponatremia
The FDA label for bupropion lists hyponatremia as a recognized adverse effect, noting that metabolic disorders including hyponatremia can increase seizure risk in patients taking the medication 1. Multiple case reports document bupropion-associated hyponatremia in clinical practice 2, 3, 4, though the overall incidence appears substantially lower than with serotonergic antidepressants 5.
Relative Risk Compared to Other Antidepressants
Bupropion carries a significantly lower risk of hyponatremia than SSRIs, SNRIs, or mirtazapine 5. A comprehensive review of antidepressant-induced hyponatremia in older adults found that SSRIs, SNRIs, and mirtazapine were implicated in the majority of case reports and clinical studies, while bupropion was implicated far less often 5. Given its unique dopaminergic/noradrenergic mechanism of action (rather than serotonergic), bupropion may be the most appropriate antidepressant choice for older adults at high risk for antidepressant-induced hyponatremia 5.
Clinical Presentation and Mechanism
When hyponatremia does occur with bupropion, patients typically meet diagnostic criteria for syndrome of inappropriate antidiuretic hormone secretion (SIADH) 2, 6. The clinical challenge is that symptoms of hyponatremia—including confusion, lethargy, and altered mental status—can be misinterpreted as worsening depression or inadequate antidepressant response, potentially leading to inappropriate dose escalation rather than recognition of the metabolic complication 2, 6.
High-Risk Patient Populations
Clinicians should maintain heightened vigilance for hyponatremia in patients with the following risk factors 2:
- Older age (particularly ≥65 years)
- Female sex
- Concurrent diuretic use
- Low body mass index
- Baseline low-normal sodium levels
- Unexplained mental status changes at any time during treatment
Monitoring Recommendations
Check serum sodium within the first 2 weeks after initiating bupropion in high-risk patients 2. For patients who develop unexplained confusion, lethargy, or behavioral changes during treatment, obtain serum electrolytes immediately to rule out hyponatremia before attributing symptoms to psychiatric illness 2, 6.
Management of Bupropion-Induced Hyponatremia
If hyponatremia develops, discontinue bupropion immediately 2, 3, 4. The hyponatremia typically resolves after drug withdrawal 2, 3, 4. Ensure normal extracellular fluid volume through appropriate fluid management; rarely, hypertonic saline infusion may be required for severe symptomatic cases 6.
After correcting the metabolic abnormality, consider switching to an alternative antidepressant with careful sodium monitoring, or evaluate for electroconvulsive therapy if clinically warranted 6. Mirtazapine may be a reasonable alternative in patients who developed hyponatremia on bupropion and who also experience weight loss and insomnia, as mirtazapine appears to carry a low risk for this complication 2.
Critical Clinical Pitfall
The most dangerous error is misattributing hyponatremia symptoms (confusion, lethargy, altered behavior) to worsening depression rather than recognizing the metabolic emergency 2, 6. This can lead to dose escalation of the offending agent, worsening the hyponatremia and potentially precipitating seizures or other serious neurological complications 1, 2.